scholarly journals Brain Asymmetry Detection and Machine Learning Classification for Diagnosis of Early Dementia

Sensors ◽  
2021 ◽  
Vol 21 (3) ◽  
pp. 778
Author(s):  
Nitsa J. Herzog ◽  
George D. Magoulas

Early identification of degenerative processes in the human brain is considered essential for providing proper care and treatment. This may involve detecting structural and functional cerebral changes such as changes in the degree of asymmetry between the left and right hemispheres. Changes can be detected by computational algorithms and used for the early diagnosis of dementia and its stages (amnestic early mild cognitive impairment (EMCI), Alzheimer’s Disease (AD)), and can help to monitor the progress of the disease. In this vein, the paper proposes a data processing pipeline that can be implemented on commodity hardware. It uses features of brain asymmetries, extracted from MRI of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, for the analysis of structural changes, and machine learning classification of the pathology. The experiments provide promising results, distinguishing between subjects with normal cognition (NC) and patients with early or progressive dementia. Supervised machine learning algorithms and convolutional neural networks tested are reaching an accuracy of 92.5% and 75.0% for NC vs. EMCI, and 93.0% and 90.5% for NC vs. AD, respectively. The proposed pipeline offers a promising low-cost alternative for the classification of dementia and can be potentially useful to other brain degenerative disorders that are accompanied by changes in the brain asymmetries.

2019 ◽  
Vol 8 (3) ◽  
pp. 7964-7967

Alzheimer’s is a neurodegenerative disease which can eventually leads to dementia. Mostly occurring in elderly people over the age of 65, it is hard to detect and diagnose correctly. Most common symptoms include memory loss and slow deterioration of cognitive functions. Given that these symptoms are seen often in old people, this hinders the detection of Alzheimer’s disease (AD). Alzheimer’s is currently incurable, but detection of the disease during its early stage is often beneficial to the patient, since there are treatments which can considerably improve the quality of life of the patient. However this can only be done if the patient has been diagnosed at a stage before any permanent brain damage has been done. Most of the current methods for detecting and diagnosing AD are not good enough. It is the need of the hour to develop better and early diagnostic tools. With the improvements in the field of machine learning, we now have the tools needed to drastically improve detection of Alzheimer’s. We examine various machine learning methods and algorithms to find a method which can boost the chances of detecting the disease. We will use the following algorithms: Decision Tree, SVM, Random Forest and Adaboost. The dataset being used is the longitudinal MRI data available included in the OASIS dataset. We will use the aforementioned algorithms on the dataset and compare the accuracies achieved to find an optimal.


2013 ◽  
Vol 9 ◽  
pp. P375-P375
Author(s):  
Motonobu Fujishima ◽  
Norihide Maikusa ◽  
Noriko Chida ◽  
Hiroshi Matsuda ◽  
Fumio Yamashita ◽  
...  

2019 ◽  
Author(s):  
Massimiliano Grassi ◽  
Nadine Rouleaux ◽  
Daniela Caldirola ◽  
David Loewenstein ◽  
Koen Schruers ◽  
...  

ABSTRACTBackgroundDespite the increasing availability in brain health related data, clinically translatable methods to predict the conversion from Mild Cognitive Impairment (MCI) to Alzheimer’s disease (AD) are still lacking. Although MCI typically precedes AD, only a fraction of 20-40% of MCI individuals will progress to dementia within 3 years following the initial diagnosis. As currently available and emerging therapies likely have the greatest impact when provided at the earliest disease stage, the prompt identification of subjects at high risk for conversion to full AD is of great importance in the fight against this disease. In this work, we propose a highly predictive machine learning algorithm, based only on non-invasively and easily in-the-clinic collectable predictors, to identify MCI subjects at risk for conversion to full AD.MethodsThe algorithm was developed using the open dataset from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), employing a sample of 550 MCI subjects whose diagnostic follow-up is available for at least 3 years after the baseline assessment. A restricted set of information regarding sociodemographic and clinical characteristics, neuropsychological test scores was used as predictors and several different supervised machine learning algorithms were developed and ensembled in final algorithm. A site-independent stratified train/test split protocol was used to provide an estimate of the generalized performance of the algorithm.ResultsThe final algorithm demonstrated an AUROC of 0.88, sensitivity of 77.7%, and a specificity of 79.9% on excluded test data. The specificity of the algorithm was 40.2% for 100% sensitivity.DiscussionThe algorithm we developed achieved sound and high prognostic performance to predict AD conversion using easily clinically derived information that makes the algorithm easy to be translated into practice. This indicates beneficial application to improve recruitment in clinical trials and to more selectively prescribe new and newly emerging early interventions to high AD risk patients.


Author(s):  
Adwait Patil

Abstract: Alzheimer’s disease is one of the neurodegenerative disorders. It initially starts with innocuous symptoms but gradually becomes severe. This disease is so dangerous because there is no treatment, the disease is detected but typically at a later stage. So it is important to detect Alzheimer at an early stage to counter the disease and for a probable recovery for the patient. There are various approaches currently used to detect symptoms of Alzheimer’s disease (AD) at an early stage. The fuzzy system approach is not widely used as it heavily depends on expert knowledge but is quite efficient in detecting AD as it provides a mathematical foundation for interpreting the human cognitive processes. Another more accurate and widely accepted approach is the machine learning detection of AD stages which uses machine learning algorithms like Support Vector Machines (SVMs) , Decision Tree , Random Forests to detect the stage depending on the data provided. The final approach is the Deep Learning approach using multi-modal data that combines image , genetic data and patient data using deep models and then uses the concatenated data to detect the AD stage more efficiently; this method is obscure as it requires huge volumes of data. This paper elaborates on all the three approaches and provides a comparative study about them and which method is more efficient for AD detection. Keywords: Alzheimer’s Disease (AD), Fuzzy System , Machine Learning , Deep Learning , Multimodal data


2021 ◽  
pp. 177-191
Author(s):  
Natalia V. Revollo ◽  
G. Noelia Revollo Sarmiento ◽  
Claudio Delrieux ◽  
Marcela Herrera ◽  
Rolando González-José

Sign in / Sign up

Export Citation Format

Share Document